PERI-EDU University Education
Implant placement creates a controlled wound. The early inflammatory response initiates defence, debris clearance, vascular repair and bone remodelling. Successful healing requires this response to resolve and transition toward tissue formation. Persistent inflammatory and metabolic stress may disturb that sequence, but implant risk remains multifactorial and must be interpreted from the complete clinical context.
Inflammation is part of healing
Blood contacts the implant surface immediately after placement. Protein adsorption, coagulation and complement activation are followed by recruitment of neutrophils, monocytes and macrophages. These events prepare the surgical site for angiogenesis, progenitor-cell recruitment and tissue reconstruction.
The biological target is not complete suppression of inflammation. An inadequate early response can impair wound defence, while excessive or persistent activation can damage tissue. Timing, magnitude and resolution are more informative than the presence of inflammation alone.
| Controlled acute response | Persistent dysregulated response |
|---|---|
| Begins rapidly after surgical injury. | Continues beyond the period required for repair. |
| Supports debris clearance and antimicrobial defence. | Maintains cytokine, proteolytic and oxidative activity. |
| Promotes vascular ingrowth and progenitor-cell recruitment. | Can impair vascular function and cellular metabolism. |
| Transitions toward matrix formation and remodelling. | Delays or distorts the transition toward repair. |
The healing sequence around an implant
| Phase | Principal events | Potential disruption |
|---|---|---|
| Haemostasis | Clot formation, fibrin matrix and provisional wound stability. | Excessive bleeding, poor clot stability or vascular compromise. |
| Early inflammation | Immune-cell recruitment, debris clearance and cytokine signalling. | Persistent infection, excessive trauma or dysregulated response. |
| Tissue formation | Angiogenesis, fibroblast activity, osteogenic differentiation and osteoid formation. | Hypoxia, hyperglycaemia, smoking or continued inflammation. |
| Remodelling | Coupled osteoclast and osteoblast activity and maturation of peri-implant bone. | Micromotion, overload, chronic inflammation or poor maintenance. |
Primary stability is mechanical and depends on implant geometry, surgical preparation and local bone conditions. Secondary stability develops biologically as new bone forms and remodels at the interface. Excessive micromotion can disrupt this transition even in a metabolically healthy patient.
Osteoimmunology at the bone-implant interface
Bone and immune cells operate within one regulatory network. Immune cells influence osteogenic progenitors, osteoblasts and osteoclasts; bone cells produce signals that regulate immune-cell recruitment and function.
- Neutrophils: early antimicrobial defence, debris clearance and inflammatory signalling.
- Monocytes and macrophages: phagocytosis, inflammatory regulation, resolution, angiogenesis and repair.
- Lymphocytes: adaptive regulation and cytokine control of bone-cell pathways.
- Mesenchymal progenitors: osteogenic and stromal differentiation.
- Osteoblast-lineage cells: osteoid production, mineralization and regulation of osteoclast signals.
- Osteoclasts: removal of damaged bone and coupled remodelling.
The M1/M2 macrophage model illustrates inflammatory and reparative tendencies, but actual macrophage states form a changing spectrum. Successful repair depends on appropriate sequencing and plasticity rather than a permanent switch to one phenotype.
RANKL, osteoprotegerin and coupled remodelling
RANKL binds RANK on osteoclast precursors and promotes their differentiation and activity. Osteoprotegerin acts as a decoy receptor that limits RANKL signalling. The local balance is influenced by osteoblast-lineage cells, osteocytes, immune cells, mechanical loading and inflammatory cytokines.
IL-1 beta, TNF-alpha and IL-6-related pathways can support osteoclastogenesis in inflammatory environments. Osteoclast activity is nevertheless necessary for normal repair. Pathology develops when resorption becomes excessive, persistent or uncoupled from formation.
Redox balance in bone repair
Reactive oxygen species are produced during mitochondrial metabolism and immune-cell activity. At controlled levels they function as signalling molecules. Oxidative stress develops when oxidant production exceeds antioxidant and repair capacity.
Persistent excess ROS may damage proteins, lipids, nucleic acids and mitochondrial function. It can reduce osteoblast differentiation and matrix formation, alter progenitor-cell fate and support resorptive pathways in inflammatory settings.
Mechanistic evidence does not justify routine high-dose antioxidant supplementation for implant patients. Supplements may have adverse effects and should not substitute for treatment of diabetes, smoking, infection or a documented nutritional deficiency.
Metainflammation as a biological framework
Metainflammation describes persistent low-grade immune activation associated with metabolic dysfunction and chronic nutrient excess. It is a mechanistic framework rather than a stand-alone dental diagnosis. Adipose tissue, liver, skeletal muscle, vascular endothelium and circulating immune cells may all contribute.
| Metabolic context | Potential pathway | Evidence boundary |
|---|---|---|
| Type 2 diabetes and hyperglycaemia | Advanced glycation, microvascular dysfunction, altered immune response and impaired bone-cell activity. | Risk varies with glycaemic control, comorbidity and study design. |
| Obesity and adipose dysfunction | Adipokine imbalance, insulin resistance and low-grade inflammatory signalling. | Obesity alone does not consistently predict implant failure. |
| Dyslipidaemia | Oxidized lipids, endothelial effects and oxidative stress may influence bone metabolism. | Direct implant-specific clinical thresholds are lacking. |
| Metabolic liver disease | Shares insulin resistance, lipid dysregulation and inflammatory pathways. | Implant-specific clinical evidence remains limited. |
| Chronic stress and sleep disruption | Neuroendocrine, behavioural and metabolic pathways may modify immunity and self-care. | Associations are multifactorial and difficult to isolate. |
Systemic conditions and implant outcomes
Diabetes
Diabetes is not an automatic contraindication to implant therapy. Current glycaemic control, complications, medications and maintenance capacity are more informative than the diagnostic label alone. Poor control is biologically and clinically more concerning than stable, well-managed disease.
Obesity and metabolic syndrome
Obesity may be associated with peri-implant inflammatory measures in some studies, but a recent meta-analysis did not identify a statistically significant increase in implant failure. Heterogeneity was substantial. Body mass index alone should not determine implant candidacy.
Dyslipidaemia and metabolic liver disease
Mechanistic research links oxidized lipids and metabolic inflammation with altered bone biology. Direct evidence that lipid or liver markers independently predict implant failure remains insufficient for universal thresholds.
Vitamin D
Vitamin D participates in mineral metabolism and immune regulation, but routine screening or supplementation solely to improve implant outcomes is not established for every patient. Testing should follow medical indications, deficiency risk and local standards.
Smoking
Smoking affects vascular function, immune responses and wound healing. Support for cessation should form part of risk reduction without framing smoking status as a deterministic guarantee of success or failure.
Pre-operative assessment and risk modification
- Identify active local disease: treat periodontitis, acute infection and uncontrolled plaque before elective implant surgery.
- Assess systemic stability: clarify current diagnoses, metabolic control, medications and relevant complications.
- Use targeted tests when indicated: HbA1c, blood count, CRP, lipids, vitamin D or other tests should answer a defined question based on history or coordinated medical care.
- Optimize modifiable factors: support smoking cessation, metabolic control, nutrition, sleep, hygiene and maintenance.
- Adapt treatment and follow-up: match staging, loading and recall to combined local and patient risk.
CBC-derived indices, CRP or metabolic risk alone do not create an indication for antibiotics. Antimicrobial decisions should follow infection status, procedure-specific guidance, patient factors and antimicrobial-stewardship principles.
Clinical and biological synthesis
- Early inflammation is necessary for wound defence and initiation of repair.
- Inflammatory resolution and transition toward vascular and osteogenic repair are active processes.
- Osseointegration depends on coordinated immune, vascular, osteoblast and osteoclast functions.
- Excess oxidative and metabolic stress may impair healing, but clinical risk is multifactorial.
- Diabetes, obesity and dyslipidaemia should be interpreted through current control and associated complications.
- Local infection, implant stability, position, prosthetic access and loading remain essential explanations for complications.
- Laboratory testing should be targeted to the medical history and an actionable clinical question.
Download the full educational material
The extended PDF presents the complete healing sequence, osteoimmune cell network, RANKL-OPG regulation, redox biology, metabolic modifiers and an evidence-calibrated pre-operative assessment pathway.
Download the full educational material (PDF)
Selected references
- Wang J, et al. Osteoimmunology drives dental implant osseointegration: a new paradigm for implant dentistry. 2021. PMID: 33737990.
- Osteoimmune regulation underlies oral implant osseointegration and its perturbation. 2023. PMID: 36761175.
- Innate immune regulation in dental implant osseointegration. 2024. PMID: 38346728.
- Macrophages in the process of osseointegration around the implant and their regulatory strategies. 2024. PMID: 38166507.
- Navigating oxidative stress in oral bone regeneration: mechanisms and reactive oxygen species-regulating biomaterial strategies. 2025. PMID: 41048977.
- Adipose tissue dysfunction: impact on bone and osseointegration. 2021. PMID: 34374815.
- Diabetes mellitus and dental implants: a systematic review and meta-analysis. 2022. PMID: 35591561.
- Systematic review on diabetes mellitus and dental implants: an update. 2022. PMID: 34978649.
- Impact of obesity on dental implant failure and peri-implant health: a systematic review and meta-analysis. 2026. PMID: 41692721.
- Osteoimmune regulation in dental implant osseointegration: from foreign body response to therapeutic immunomodulation. 2026. PMID: 41878121.
Explore related PERI-EDU resources
#UniversityEducation #OnlineCourses #ClinicalCases #PERIEDU #Metainflammation #Osteoimmunology #ImplantHealing #OxidativeStress
This educational material does not replace individual clinical assessment, medical evaluation, laboratory interpretation or procedure-specific guidance.
This work was co-funded by the European Union under grant agreement No. 2024-1-PL01-KA220-HED-000251208. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the Foundation for the Development of the Education System (FRSE). Neither the European Union nor FRSE can be held responsible for them.